I. - Basic information

I.1 - Surname

Škereňová

I.2 - Name

Mária

I.3 - Degrees

RNDr., PhD.

I.4 - Year of birth

1966

I.5 - Name of the workplace

Biomedical Centre, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava

I.6 - Address of the workplace

Malá hora 4C, 03601 Martin

I.7 - Position

researcher

I.8 - E-mail address

maria.skerenova@uniba.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://www.portalvs.sk/regzam/detail/28525

I.10 - Name of the study field in which a person works at the university

Medical, clinical and pharmaceutical biochemistry

I.11 - ORCID iD

https://orcid.org/0000-0001-8015-4664

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.a - Name of the university or institution

Faculty of Natural Sciences, Comenius University in Bratislava

II.b - Year

1989

II.c - Study field and programme

biochemistry

II.3 - Third degree of higher education

II.a - Name of the university or institution

Jessenius Faculty of Medicine, Comenius University Bratislava

II.b - Year

2017

II.c - Study field and programme

Medical, clinical and pharmaceutical biochemistry

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
researcher	Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava	2017 -
laboratory diagnostician	University Hospital Martin, Department of Clinical Biochemistry	1989 -

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.2 - Number of defended theses

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

217

VI.1.b - Over the last six years

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

550

VI.1.b - Over the last six years

294

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

333

VI.1.b - Over the last six years

216

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

Pullmann R Jr, Lukác J, Skerenová M, Rovensky J, Hybenová J, Melus V, Celec S, Pullmann R, Hyrdel R. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1999 Nov-Dec;17(6):725-9. PMID: 10609073.

Zubor P, Dokus K, Zigo I, Skerenova M, Pullmann R, Danko J. TNF α G308A gene polymorphism has an impact on renal function, microvascular permeability, organ involvement and severity of preeclampsia. Gynecol Obstet Invest. 2014;78(3):150-61. doi: 10.1159/000364865. Epub 2014 Jul 22. PMID: 25059926.

Sokol J, Skerenova M, Biringer K, Simurda T, Kubisz P, Stasko J. Glycoprotein VI Gene Variants Affect Pregnancy Loss in Patients With Platelet Hyperaggregability. Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):202S-208S. doi: 10.1177/1076029618802358. Epub 2018 Oct 2. PMID: 30278775; PMCID: PMC6714835.

Lasabova Z, Zigo I, Svecova I, Szabo G, Stanclova A, Skerenova M, Zubor P, Biskupska-Bodova K, Rigo J, Nagy B, Danko J. Association of specific diplotypes defined by common rs1800682 and rare rs34995925 single nucleotide polymorphisms within the STAT1 transcription binding site of the FAS gene promoter with preeclampsia. Gen Physiol Biophys. 2014;33(2):199-204. doi: 10.4149/gpb_2013081. Epub 2014 Jan 22. PMID: 24448373.

Škereňová M, Sokol J, Biringer K, Ivanková J, Staško J, Kubisz P, Lasabová Z. GP6 Haplotype of Missense Variants is Associated with Sticky Platelet Syndrome Manifested by Fetal Loss. Clin Appl Thromb Hemost. 2018 Jan;24(1):63-69. doi: 10.1177/1076029616685428. Epub 2017 Jan 2. PMID: 28041267; PMCID: PMC6714632.

VI.3 - The most significant research/artistic/other outputs over the last six years

Dohál M, Dvořáková V, Šperková M, Pinková M, Spitaleri A, Norman A, Cabibbe AM, Rasmussen EM, Porvazník I, Škereňová M, Solovič I, Cirillo DM, Mokrý J. Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020. Sci Rep. 2022 May 3;12(1):7149. doi: 10.1038/s41598-022-11287-5. PMID: 35505072; PMCID: PMC9062869.

Dohál M, Dvořáková V, Šperková M, Pinková M, Spitaleri A, Rasmussen EM, Škereňová M, Krivošová M, Gondáš E, Porvazník I, Solovič I, Cirillo DM, Mokrý J. Resistance patterns and transmission of mono- and polyresistant TB: clinical impact of WGS. JAC Antimicrob Resist. 2023 Oct 4;5(5):dlad108. doi: 10.1093/jacamr/dlad108. PMID: 37799267; PMCID: PMC10549209.

Mikolajcikova S, Lasabova Z, Holubekova V, Skerenova M, Zibolenova J, Matasova K Sr, Zibolen M, Calkovska A. The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates. Front Pediatr. 2022 May 25;10:851042. doi: 10.3389/fped.2022.851042. PMID: 35692980; PMCID: PMC9174893.

Rusňáková D, Sedláčková T, Radvák P, Böhmer M, Mišenko P, Budiš J, Bokorová S, Lipková N, Forgáčová-Jakúbková M, Sládeček T, Sitarčík J, Krampl W, Gažiová M, Kaliňáková A, Staroňová E, Tichá E, Vrábľová T, Ševčíková L, Kotvasová B, Maďarová L, Feiková S, Beňová K, Reizigová L, Onderková Z, Ondrušková D, Loderer D, Škereňová M, Danková Z, Janíková K, Halašová E, Nováková E, Turňa J, Szemes T. Systematic Genomic Surveillance of SARS-CoV-2 Virus on Illumina Sequencing Platforms in the Slovak Republic-One Year Experience. Viruses. 2022 Nov 2;14(11):2432. doi: 10.3390/v14112432. PMID: 36366530; PMCID: PMC9697771.

Skerenova M, Cibulka M, Dankova Z, Holubekova V, Kolkova Z, Lucansky V, Dvorska D, Kapinova A, Krivosova M, Petras M, Baranovicova E, Baranova I, Novakova E, Liptak P, Banovcin P, Bobcakova A, Rosolanka R, Janickova M, Stanclova A, Gaspar L, Caprnda M, Prosecky R, Labudova M, Gabbasov Z, Rodrigo L, Kruzliak P, Lasabova Z, Matakova T, Halasova E. Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort. Adv Med Sci. 2024 Mar;69(1):198-207. doi: 10.1016/j.advms.2024.03.007. Epub 2024 Mar 28. PMID: 38555007.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

Stoycheva K, Cristea V, Ködmön C, Rosales-Klintz S, Zenner D, Vasiliu A, van der Werf M, Lange C. Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022. Euro Surveill. 2024 Mar;29(12):2400094. doi: 10.2807/1560-7917.ES.2024.29.12.2400094. PMID: 38516786; PMCID: PMC11063674.

cited:

Dohál M, Dvořáková V, Šperková M, Pinková M, Ghodousi A, Omrani M, Porvazník I, Rasmussen EM, Škereňová M, Krivošová M, Wallenfels J, Konstantynovska O, Walker TM, Nikolayevskyy V, Cirillo DM, Solovič I, Mokrý J. Tuberculosis in Ukrainian War Refugees and Migrants in the Czech Republic and Slovakia: A Molecular Epidemiological Study. J Epidemiol Glob Health. 2024 Mar;14(1):35-44. doi: 10.1007/s44197-023-00166-5. Epub 2023 Dec 4. Erratum in: J Epidemiol Glob Health. 2024 Sep;14(3):1363-1364. doi: 10.1007/s44197-024-00212-w. PMID: 38048026; PMCID: PMC11043285.

Marongiu F, Ruberto MF, Marongiu S, Mameli A, Barcellona D. Do we need more guidance on thrombophilia testing? Challenges and special considerations. Expert Rev Hematol. 2024 Jan-Mar;17(1-3):27-37. doi: 10.1080/17474086.2024.2306821. Epub 2024 Jan 22. PMID: 38228491.

cited:

Sokol J, Skerenova M, Ivankova J, Simurda T, Stasko J. Association of Genetic Variability in Selected Genes in Patients With Deep Vein Thrombosis and Platelet Hyperaggregability. Clin Appl Thromb Hemost. 2018 Oct;24(7):1027-1032. doi: 10.1177/1076029618779136. Epub 2018 Jun 4. PMID: 29865896; PMCID: PMC6714740.

Guillouzouic A, Gaudart A, Tessier E, Risso K, Hamdad F, Alauzet C, Vaillant P, Koebel C, Kassegne L, Chenouard R, Abgueguen P, Le Brun C, Jamard S, Lecomte R, Lefebvre M, Bémer P. Xpert MTB/RIF Ultra Trace Results: Decision Support for the Treatment of Extrapulmonary Tuberculosis in Low TB Burden Countries. J Clin Med. 2023 Apr 27;12(9):3148. doi: 10.3390/jcm12093148. PMID: 37176590; PMCID: PMC10179111.

cited:

Kohler C, King J, Stacker L, Goller KV, Moritz J, Pohlmann A, Nath N, Tzvetkova A, Rieck M, Paraskevopoulou S, Beslic D, Hölzer M, Fuchs S, Ziemann J, Kaderali L, Beer M, Hübner NO, Becker K. Neighbourhood watch: genomic epidemiology of SARS-CoV-2 variants circulating in a German federal state, Mecklenburg-Western Pomerania, in 2020-2022. Emerg Microbes Infect. 2023 Dec;12(2):2245916. doi: 10.1080/22221751.2023.2245916. PMID: 37585712; PMCID: PMC10446807.

cited:

Dalby A, Mezzano D, Miquel JF, Rivera J, Watson SP, Morgan NV. Introduction of an ancient founder glycoprotein VI mutation into the Chilean population. Blood Adv. 2022 Nov 22;6(22):5866-5869. doi: 10.1182/bloodadvances.2022008531. Erratum in: Blood Adv. 2024 Aug 27;8(16):4397. doi: 10.1182/bloodadvances.2024014086. PMID: 35994634; PMCID: PMC9647427.

cited:

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

New possibilities of laboratory diagnostics and massive screening of SARS-Cov-2 and identification of mechanisms of virus behavior in the human body. ITMS 313011AUA4. Period: 2020-2023. Position: researcher. Link: https://www.jfmed.uniba.sk/fileadmin/jlf/Pracoviska/centrum-pre-podporu-vedy-vyskumu-a-vyvoja/2022/webpage_COVLAB.pdf

Integrative strategy in the development of personalized medicine of selected cancers and its impact on quality of life. ITMS 313011V446. Period: 2020-2023. Position: researcher. Link: https://www.jfmed.uniba.sk/fileadmin/jlf/Pracoviska/centrum-pre-podporu-vedy-vyskumu-a-vyvoja/2020/web_LISPER.docx.pdf

Systemic Public Research Infrastructure - Biobank for Cancer and Rare diseases, BIOFORD, ITMS: 313011AFG5. Period: 2020-2023. Position: researcher. Link: https://www.jfmed.uniba.sk/fileadmin/jlf/Pracoviska/centrum-pre-podporu-vedy-vyskumu-a-vyvoja/2020/Info_BIOFORD.pdf or https://www.biobankslovakia.sk/

Long-term strategic research of prevention, intervention and mechanisms of obesity and its comorbidities, IMTS: 313011V344. https://www.jfmed.uniba.sk/fileadmin/jlf/Pracoviska/centrum-pre-podporu-vedy-vyskumu-a-vyvoja/2020/Info_OBEZITA.pdf

APVV-15-0181 "Development of new methods for monitoring therapeutic resistance in prostate cancer." 2016 - 2020

Name and surname:	RNDr. Mária Škereňová, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.3 - Third degree of higher education

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.2 - Number of defended theses

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

VI.3 - The most significant research/artistic/other outputs over the last six years

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts